Zosuquidar (LY335979) 3HCl: Redefining P-gp Inhibition in...
2026-01-20
Explore how Zosuquidar (LY335979) 3HCl, a leading P-glycoprotein modulator, advances multidrug resistance (MDR) reversal in cancer through next-generation pharmacokinetic and transporter insights. This article uniquely integrates transporter network biology and clinical translation for oncology research.